Embracing Diversity & Inclusion

1. Turning Point In U.S. History: Our Chance To Do Better With Clinical Trials 2/16/2021

   We are at the beginning of important conversations. Conversations that need to happen so we can definitively address the health disparities that continue to impact outcomes among ethnic and racial groups in the United States. 

2. Addressing Disparities And The Democratization Of Clinical Trials 1/14/2021

   Advancements of the protocols, tools, and technologies that were highly leveraged during the COVID-19 pandemic are the key to breaking down the barriers that perpetuate clinical trial disparities.

3. Let’s Tackle The Hidden Real-World Reasons For Poor Clinical Trial Diversity 12/17/2020

   To achieve better outcomes and health equity for historically underserved populations, we must address the not widely acknowledged, hidden, real-world reasons for such poor diversity in clinical trials. Here, we will pull back the covers on the issues we must tackle to improve diversity in trials. 

4. How EMD Serono Is Bringing Diverse Patient Voices Together 11/3/2020

   The pandemic has created an opportunity to address some of the causes underlying clinical care inequities. And while combatting these issues will take time, much can be done by first addressing the gap for minorities in clinical trials. This is a topic I am passionate about both personally and professionally as a female Hispanic chief medical officer.

5. Increasing Diversity In Clinical Trials: The Critical Role Of Community Partnerships & Collaborations 10/6/2020

   Meaningful long-term engagement, collaborations, and partnerships — rather than those based on specific trial or project needs — deepen community relationships, build trust, gain an understanding of community priorities, and make research programs more responsive to the needs, values, and perspectives of the affected populations. 

6. 9 Factors For Driving Inclusivity & Patient Centricity In A Transformed Clinical Trials Landscape 9/15/2020

   Patient-centricity, quality, and inclusion are not natural consequences of the shift to virtual clinical trials. To be intentional with the design, we must start with articulating and understanding the full contexts of patients’ lives, medical and beyond.

7. How FDA Is Helping Advance Clinical Trial Diversity 9/1/2020

   An update from the FDA Office of Minority Health and Health Equity on its efforts to address health disparities and health equity — and ultimately strengthen the agency’s ability to respond to minority health concerns.

8. How Can We Begin To Solve Unconscious Systemic Bias In Clinical Trials? 8/4/2020

   Halting disparities in clinical trials during the time of COVID-19 will take eradicating unconscious bias, building trust in diverse communities, dispelling long-held myths, constructing relationships, and educating patients, family members, and physicians.

9. 6 Practical Ways To Increase Diversity In Clinical Trials 6/11/2020

   Even when a certain disease is more prevalent in a particular minority population, it can still be difficult for trial investigators to reach the right individuals. As an industry — as a group of researchers dedicating our lives to improve the health of others, regardless of their race, age, gender, or disease — how can we do better?

10. Diverse Enrollment In Clinical Trials: What Do Successful Research Sites Have In Common? 5/19/2020

    Diverse enrollment in clinical research studies is a complex issue that has multifaceted implications for clinical research sites. An understanding of the research site community’s perceived awareness and current ability to enroll these populations is lacking in the clinical trials landscape.